Joanna Neill

Joanna Neill is a Professor of Psychopharmacology at the Manchester Pharmacy School, University of Manchester. She previously held professorial roles at the University of Bradford and worked in pharmaceutical industries including Merrell Dow and Merck. Her research focuses on developing preclinical models for psychiatric disorders, with recent projects involving ADHD, Alzheimer's disease, and schizophrenia cognition studies. She leads a team of 4 PhD students, 2 research technicians, and a post-doctoral researcher, presenting at ~5 conferences annually.

• Educations: BSc Pharmacology (University of Bath, 1986), PhD Psychopharmacology (University of Birmingham, 1990)
• Leadership Roles: BAP President (2016-2018), Meetings Secretary (2010-2013), REF Panel Member (2011-2014)
• Collaborations: Industry partnerships with GSK, Lundbeck, Janssen, and academic networks across 3 continents
• Established b-neuro CRO with Drs Harte and Grayson

Research interests include antipsychotic side-effects mechanisms, gonadal steroid effects during pregnancy, and translational biomarkers for schizophrenia. She is a Key Opinion Leader for Servier/Roche/Organon and a frequent conference speaker.

• Awards: Over 70 peer-reviewed publications, associate editor for Neuroscience Letters
• Grants: Funded collaborations with 10+ pharmaceutical companies

Labs/Teams: Active in Digital Futures and Lydia Becker Institute initiatives, with recent work on dopamine's role in attention disorders and cancer therapy cognitive deficits.